Bovine colostrum modulates immune activation cascades in human peripheral blood mononuclear cells in vitro

New Microbiologica

Volumn 33, Issue 2, 2010, Pages 129-135

  Jenny, Marcel ^a   Pedersen, Ninfa R ^b,c   Hidayat, Budi J ^b   Schennach, Harald ^d   Fuchs, Dietmar ^a  

^a AALBORG UNIVERSITY   (Denmark)

^b NANOKO A/S   (Denmark)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Bovine colostrum; Indoleamine 2,3 dioxygenase; Neopterin; Peripheral blood mononuclear cells; Tryptophan

Indexed keywords

IMMUNOLOGIC FACTOR; LACTOFERRIN; LACTOSE; NEOPTERIN; TRYPTOPHAN;

ANIMAL; ARTICLE; CATTLE; CELL CULTURE; CHEMISTRY; COLOSTRUM; DOSE RESPONSE; FEMALE; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MONONUCLEAR CELL; TH1 CELL;

ANIMALS; CATTLE; CELLS, CULTURED; COLOSTRUM; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; LACTOFERRIN; LACTOSE; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; NEOPTERIN; TH1 CELLS; TRYPTOPHAN;

BOVINAE;

EID: 77952710947     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. ANTONIUS C.M. (2000). In vivo antimicrobial and antiviral activity of components in bovine mild and Colostrums involved in non-specific defence. Br. J. Nutr. 84, 127-134.
2. BISWAS P., VECCHI A., MANTEGANI P., MANTELLI B., FORTIS C., AND LAZZARIN A. (2007). Immunomodulatory effects of bovine colostrum in human peripheral blood mononuclear cells. New Microbiol. 30 (4), 447-454. (Pubitemid 350183844)
3. BITZAN M.M., GOLD B.D., PHILPOTT D.J., HUESCA M., SHERMAN P.M., KARCH H., LISSNER R., LINGWOOD C.A., AND KARMALI M.A. (1998). Inhibition of Helicobacter pylori and Helicobacter mustelae binding to lipid receptors by bovine colostrum. J. Infect. Dis. 177 (4), 955-961.
4. BOESMAN-FINKELSTEIN M., AND FINKELSTEIN R. (1989) Passive oral immunization of children. Lancet 2, 1336.
5. BOGSTEDT A.K., JOHANSEN K., HATTA H., KIM M., CASSWALL T., SVENSSON L., HAMMARSTRÖM, L. (1996). Passive immunity against diarrhoea. Acta Paediatr. 85 (2), 125-128.
6. BRINKWORTH G.D., BUCKLEY J.D. (2003). Concentrated bovine Colostrums protein supplementation reduces the incidence of self-reported symptoms of upper respiratory tract infection in adult males. Eur. J. Nutr. 42 (4), 228-232.
7. CACCAVO D., PELLEGRINO N.M., ALTAMURA M., RIGON A., AMATI L., AMOROSO A., JIRILO W. (2002). Antimicrobial and immunoregulatory functions of lactoferrin and its potential merapeutic application. J. of Endotoxin Res. 8 (6), 403-417.
8. CONNEELY O.M. (2001). Antiinflammatory activities of lactoferrin. J. Am. Coll. Nutr. 20, 389-395.
9. DAVIDSON G.P., WHYTE P.B., DANIELS E., FRANKLIN K., NUNAN H., MCCLOUD P.I., MOORE A.G., MOORE D.J. (1989). Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. Lancet 23 (2), 709-712.
10. ELFSTRAND L. (2002). Immunoglobulins, growth factors and growth hormone in bovine colostrum and the effects of processing. Int. Dairy J. 12, 879-887. (Pubitemid 36021671)
11. EILIPP D., ALIZADEH-KHIAVI K., RICHARDSON C., PALMA A., PAREDES N., TAKEUCHI O., AKIRA S., JULIUS M. (2001). Soluble CD14 enriched in colostrum and milk induces B cell growth and differentiation. Proc. Natl. Acad Sci. (USA) 98, 603-608.
12. FLOREN C.H., CHINENYE S., ELFSTRAND L., HAGMAN C., IHSE I. (2006). ColoPlus, a new product based on bovine colostrum, alleviates HIV-associated diarrhoea. Scand. J. Gastroenterol. 41, 682-686.
13. HAGIWARA K., KATAOKA S., YAMANAKA H., KIRISAWA R., IWAI H. (2000). Detection of cytokines in bovine colostrum. Vet Immunol. Immunopathol. 76 (3-4), 183-190.
14. HAGIWARA K., KITAJIMA K., YAMANAKA H., KIRISAWA R., IWAI H. (2005). Development of a sandwich ELISA assay for measuring bovine soluble type II IL-1 receptor (IL1R2) concentration in serum and milk. Cytokine. 32 (3-4), 132-136.
15. HUBER C., BATCHELOR J.R., FUCHS D., HAUSEN A., LANG A., NIEDERWIESER D., REIBNEGGER G., SWETLY P., TROPPMAIR J., WACHTER H. (1984). Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J. Exp. Med. 160, 310-316.
16. KAUSHIK S., TRIVEDI S.S., JAIN A., BHATTACHARJEE J. (2002). Unusual changes in colostrum composition in lactating Indian women having medical complications during pregnancy. A pilot study. Indian. J. Clin. Biochem. 17, 68-73.
17. MOSMANN T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Iimmunol. Methods. 65, 55-63.
18. MURR C., WIDNER B., WIRLEITNER B., FUCHS D. (2002). Neopterin as a marker for immune system activation. Curr. Drug. Metab. 3, 175-187. (Pubitemid 34326529)
19. OGRA S.S., OGRA P.L. (1978). Immunologic aspects of human colostrum and milk. Journal of Pediatrics. 92, 546-549.
20. OZAKI Y., EDELSTEIN M.P., DUCH D.S. (1988). Induction of indoleamine 2,3- dioxygenase: amechanism of the antitumor activity of interferon-gamma. Proc. Natl. Acad Sci. (USA) 85, 1242-1246.
21. PAKKANEN R., AALTO J. (1997). Growth factors and antimicrobial factors of bovine colostrum. Int. Dairy J. 7, 285-297.
22. PFEFFERKORN E.R. (1986). Interferon-y blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad Sci. (USA) 81, 908-912.
23. PLAYFORD R.J., MACDONALD C.E., JOHNSON W.S. (2000). Colostrum and milk-derived peptide growth factors for the treatment of gastro-intestinal disorders. Am. J. Clin. Nutr. 72, 5-14.
24. SABIN A.B., FIELDSTEEL A.H. (1962). Antipoliomyelitic activity of human and bovine colostrum and milk. Pediatrics. 29, 105-115.
25. SHING C.M., PEAKE J.M., SUZUKI K., JENKINS D.G., COOMBES J.S. (2009). Bovine colostrum modulates cytokine production in human peripheral blood mononuclear cells stimulated with lipopolysaccharide and phytohemagglutinin. J. Interferon. Cytokine. Res. 29 (1) 37-44.
26. SIGTHORSSON G., TIBBLE J., HAYLLAR J., MENZIES I., MACPHERSON A., MOOTS R., SCOTT D., GUMPEL, M.J., BJARNASON I. (1998). Intestinal permeability and inflammation in patients on NSAIDs. Gut. 43 (4), 506-511.
27. SOLOMONS N.W. (2002). Modulation of the immune system and the response against pathogens with bovine colostrum concentrates. Eur. J. Clin. Nutr. 56 (S3), 24-28.
28. STEPHAN W., DICHTELMULLER H., LISSER R. (1990). Antibodies from colostrum in oral immunotherapy. J. Clin. Chem. Clin. Biochem. 28, 19-23.
29. STRUFF W.G., SPROTTE G. (2007). Bovine colostrum as a biologic in clinical medicine: a review. Part I: biotechnological standards, pharmacodynamic and pharmacokinetic characteristics and principles of treatment. Int. J. Clin. Pharmacol. Ther. Toxicol. 45 (4), 193-202.
30. STRUFF W.G., SPROTTE G. (2008). Bovine colostrum as a biologic in clinical medicine: a review-Part II: clinical studies. Int. J. Clin. Pharmacol. Ther. Toxicol. 46(5) 211-225.
31. TRIPATHI V., VASHISHTHA B. (2006). Bioactive compounds of bovine colostrum. Food Rev. Int. 22, 225-244.
32. VILJOEN M. (1995). Lactoferrin: a general review. Haematologica. 80, 252-267.
33. WIDNER B., WERNER E.R., SCHENNACH H, WACHTER H., FUCHS D. (1997). Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin. Chem. 43, 2424-2426.
34. WIRLEITNER B., NEURAUTER G., SCHROECKSNADEL K., FRICK B., FUCHS D. (2003). Interferon-γ-induced conversion of tryptophan: immunologic and neuropsychiatric aspects. Curr. Med. Chem. 10, 1581-1591.
35. YAMAUCHI K., TOIMITA M., GIEHL T.J., ELLISON R.T. (1993). Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect. Immun. 61, 719-728.